E Amosova, E Andrejev, I Zaderey, U Rudenko, C Ceconi, R Ferrari. Cardiovasc Drugs Ther 2011
Times Cited: 50
Times Cited: 50
Times Cited
Times Co-cited
Similarity
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
68
Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.
Jean-Claude Tardif, Piotr Ponikowski, Thomas Kahan. Eur Heart J 2009
Jean-Claude Tardif, Piotr Ponikowski, Thomas Kahan. Eur Heart J 2009
54
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
Kim Fox, Ian Ford, P Gabriel Steg, Michal Tendera, Roberto Ferrari. Lancet 2008
Kim Fox, Ian Ford, P Gabriel Steg, Michal Tendera, Roberto Ferrari. Lancet 2008
54
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Jean-Claude Tardif, Ian Ford, Michal Tendera, Martial G Bourassa, Kim Fox. Eur Heart J 2005
Jean-Claude Tardif, Ian Ford, Michal Tendera, Martial G Bourassa, Kim Fox. Eur Heart J 2005
50
Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.
Kim Fox, Ian Ford, P Gabriel Steg, Michal Tendera, Michele Robertson, Roberto Ferrari. Lancet 2008
Kim Fox, Ian Ford, P Gabriel Steg, Michal Tendera, Michele Robertson, Roberto Ferrari. Lancet 2008
42
Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
Dario DiFrancesco, John A Camm. Drugs 2004
Dario DiFrancesco, John A Camm. Drugs 2004
36
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
Gilles Montalescot, Udo Sechtem, Stephan Achenbach, Felicita Andreotti, Chris Arden, Andrzej Budaj, Raffaele Bugiardini, Filippo Crea, Thomas Cuisset, Carlo Di Mario,[...]. Eur Heart J 2013
Gilles Montalescot, Udo Sechtem, Stephan Achenbach, Felicita Andreotti, Chris Arden, Andrzej Budaj, Raffaele Bugiardini, Filippo Crea, Thomas Cuisset, Carlo Di Mario,[...]. Eur Heart J 2013
34
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.
Kim Fox, Ian Ford, Ph Gabriel Steg, Michal Tendera, Michele Robertson, Roberto Ferrari. Eur Heart J 2009
Kim Fox, Ian Ford, Ph Gabriel Steg, Michal Tendera, Michele Robertson, Roberto Ferrari. Eur Heart J 2009
32
Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.
Jeffrey S Borer, Kim Fox, Patrice Jaillon, Guy Lerebours. Circulation 2003
Jeffrey S Borer, Kim Fox, Patrice Jaillon, Guy Lerebours. Circulation 2003
28
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
Michael Böhm, Karl Swedberg, Michel Komajda, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
Michael Böhm, Karl Swedberg, Michel Komajda, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
28
Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.
Karl Werdan, Henning Ebelt, Sebastian Nuding, Florian Höpfner, Guido Hack, Ursula Müller-Werdan. Clin Res Cardiol 2012
Karl Werdan, Henning Ebelt, Sebastian Nuding, Florian Höpfner, Guido Hack, Ursula Müller-Werdan. Clin Res Cardiol 2012
28
Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial).
Maurizio Volterrani, Gennaro Cice, Giuseppe Caminiti, Cristiana Vitale, Salvatore D'Isa, Pasquale Perrone Filardi, Flavio Acquistapace, Giuseppe Marazzi, Massimo Fini, Giuseppe M C Rosano. Int J Cardiol 2011
Maurizio Volterrani, Gennaro Cice, Giuseppe Caminiti, Cristiana Vitale, Salvatore D'Isa, Pasquale Perrone Filardi, Flavio Acquistapace, Giuseppe Marazzi, Massimo Fini, Giuseppe M C Rosano. Int J Cardiol 2011
26
Ivabradine in stable coronary artery disease without clinical heart failure.
Kim Fox, Ian Ford, Philippe Gabriel Steg, Jean-Claude Tardif, Michal Tendera, Roberto Ferrari. N Engl J Med 2014
Kim Fox, Ian Ford, Philippe Gabriel Steg, Jean-Claude Tardif, Michal Tendera, Roberto Ferrari. N Engl J Med 2014
26
Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.
Jean-Claude Tardif, Eileen O'Meara, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Luigi Tavazzi, Karl Swedberg. Eur Heart J 2011
Jean-Claude Tardif, Eileen O'Meara, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Luigi Tavazzi, Karl Swedberg. Eur Heart J 2011
24
Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs.
L Simon, B Ghaleh, L Puybasset, J F Giudicelli, A Berdeaux. J Pharmacol Exp Ther 1995
L Simon, B Ghaleh, L Puybasset, J F Giudicelli, A Berdeaux. J Pharmacol Exp Ther 1995
24
Resting heart rate in cardiovascular disease.
Kim Fox, Jeffrey S Borer, A John Camm, Nicolas Danchin, Roberto Ferrari, Jose L Lopez Sendon, Philippe Gabriel Steg, Jean-Claude Tardif, Luigi Tavazzi, Michal Tendera. J Am Coll Cardiol 2007
Kim Fox, Jeffrey S Borer, A John Camm, Nicolas Danchin, Roberto Ferrari, Jose L Lopez Sendon, Philippe Gabriel Steg, Jean-Claude Tardif, Luigi Tavazzi, Michal Tendera. J Am Coll Cardiol 2007
22
Impact of ''off-label'' use of ivabradine on exercise capacity, gas exchange, functional class, quality of life, and neurohormonal modulation in patients with ischemic chronic heart failure.
Filippo M Sarullo, Giovanni Fazio, Danilo Puccio, Sergio Fasullo, Salvatore Paterna, Salvatore Novo, Pietro Di Pasquale. J Cardiovasc Pharmacol Ther 2010
Filippo M Sarullo, Giovanni Fazio, Danilo Puccio, Sergio Fasullo, Salvatore Paterna, Salvatore Novo, Pietro Di Pasquale. J Cardiovasc Pharmacol Ther 2010
25
Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Witold Ruzyllo, Michal Tendera, Ian Ford, Kim M Fox. Drugs 2007
Witold Ruzyllo, Michal Tendera, Ian Ford, Kim M Fox. Drugs 2007
22
Inadequate control of heart rate in patients with stable angina: results from the European heart survey.
Caroline A Daly, Felicity Clemens, Jose L Lopez Sendon, Luigi Tavazzi, Eric Boersma, Nicolas Danchin, François Delahaye, Anselm Gitt, Desmond Julian, David Mulcahy,[...]. Postgrad Med J 2010
Caroline A Daly, Felicity Clemens, Jose L Lopez Sendon, Luigi Tavazzi, Eric Boersma, Nicolas Danchin, François Delahaye, Anselm Gitt, Desmond Julian, David Mulcahy,[...]. Postgrad Med J 2010
31
The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease.
Steffen Gloekler, Tobias Traupe, Michael Stoller, Deborah Schild, Hélène Steck, Ahmed Khattab, Rolf Vogel, Christian Seiler. Heart 2014
Steffen Gloekler, Tobias Traupe, Michael Stoller, Deborah Schild, Hélène Steck, Ahmed Khattab, Rolf Vogel, Christian Seiler. Heart 2014
25
Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study.
Inger Ekman, Olivier Chassany, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Luigi Tavazzi, Karl Swedberg. Eur Heart J 2011
Inger Ekman, Olivier Chassany, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Luigi Tavazzi, Karl Swedberg. Eur Heart J 2011
18
Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents.
G Heusch. Br J Pharmacol 2008
G Heusch. Br J Pharmacol 2008
18
Treatment of stable angina pectoris by ivabradine in every day practice: the REDUCTION study.
Ralf Köster, Jan Kaehler, Thomas Meinertz. Am Heart J 2009
Ralf Köster, Jan Kaehler, Thomas Meinertz. Am Heart J 2009
27
Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy).
Michal Tendera, Mario Talajic, Michele Robertson, Jean-Claude Tardif, Roberto Ferrari, Ian Ford, P Gabriel Steg, Kim Fox. Am J Cardiol 2011
Michal Tendera, Mario Talajic, Michele Robertson, Jean-Claude Tardif, Roberto Ferrari, Ian Ford, P Gabriel Steg, Kim Fox. Am J Cardiol 2011
34
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL.
C Ceconi, S B Freedman, J C Tardif, P Hildebrandt, T McDonagh, P Gueret, G Parrinello, M Robertson, P G Steg, M Tendera,[...]. Int J Cardiol 2011
C Ceconi, S B Freedman, J C Tardif, P Hildebrandt, T McDonagh, P Gueret, G Parrinello, M Robertson, P G Steg, M Tendera,[...]. Int J Cardiol 2011
16
Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.
Ariel Diaz, Martial G Bourassa, Marie-Claude Guertin, Jean-Claude Tardif. Eur Heart J 2005
Ariel Diaz, Martial G Bourassa, Marie-Claude Guertin, Jean-Claude Tardif. Eur Heart J 2005
16
Ivabradine for the treatment of stable angina pectoris in octogenarians.
Ralf Koester, Jan Kaehler, Thomas Meinertz. Clin Res Cardiol 2011
Ralf Koester, Jan Kaehler, Thomas Meinertz. Clin Res Cardiol 2011
40
Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
Paul Mulder, Stephane Barbier, Abdeslam Chagraoui, Vincent Richard, Jean Paul Henry, Françoise Lallemand, Sylvanie Renet, Guy Lerebours, Florence Mahlberg-Gaudin, Christian Thuillez. Circulation 2004
Paul Mulder, Stephane Barbier, Abdeslam Chagraoui, Vincent Richard, Jean Paul Henry, Françoise Lallemand, Sylvanie Renet, Guy Lerebours, Florence Mahlberg-Gaudin, Christian Thuillez. Circulation 2004
16
Current-dependent block of rabbit sino-atrial node I(f) channels by ivabradine.
Annalisa Bucchi, Mirko Baruscotti, Dario DiFrancesco. J Gen Physiol 2002
Annalisa Bucchi, Mirko Baruscotti, Dario DiFrancesco. J Gen Physiol 2002
16
Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
Jeffrey S Borer, Jean-Yves Le Heuzey. Am J Ther 2008
Jeffrey S Borer, Jean-Yves Le Heuzey. Am J Ther 2008
19
A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction.
Matthias Manz, Marcus Reuter, Gerhard Lauck, Hegder Omran, Werner Jung. Cardiology 2003
Matthias Manz, Marcus Reuter, Gerhard Lauck, Hegder Omran, Werner Jung. Cardiology 2003
16
Differential effects of heart rate reduction and beta-blockade on left ventricular relaxation during exercise.
Patrice Colin, Bijan Ghaleh, Luc Hittinger, Xavier Monnet, Michel Slama, Jean-François Giudicelli, Alain Berdeaux. Am J Physiol Heart Circ Physiol 2002
Patrice Colin, Bijan Ghaleh, Luc Hittinger, Xavier Monnet, Michel Slama, Jean-François Giudicelli, Alain Berdeaux. Am J Physiol Heart Circ Physiol 2002
16
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey Borer, Michele Robertson, Luigi Tavazzi, Ian Ford. J Am Coll Cardiol 2012
Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey Borer, Michele Robertson, Luigi Tavazzi, Ian Ford. J Am Coll Cardiol 2012
16
I f inhibition with ivabradine : electrophysiological effects and safety.
Irina Savelieva, A John Camm. Drug Saf 2008
Irina Savelieva, A John Camm. Drug Saf 2008
16
Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.
Ph Gabriel Steg, Roberto Ferrari, Ian Ford, Nicola Greenlaw, Jean-Claude Tardif, Michal Tendera, Hélène Abergel, Kim M Fox. PLoS One 2012
Ph Gabriel Steg, Roberto Ferrari, Ian Ford, Nicola Greenlaw, Jean-Claude Tardif, Michal Tendera, Hélène Abergel, Kim M Fox. PLoS One 2012
16
Ivabradine and Bisoprolol on Doppler-derived Coronary Flow Velocity Reserve in Patients with Stable Coronary Artery Disease: Beyond the Heart Rate.
Ercole Tagliamonte, Teresa Cirillo, Fausto Rigo, Costantino Astarita, Antonino Coppola, Carlo Romano, Nicola Capuano. Adv Ther 2015
Ercole Tagliamonte, Teresa Cirillo, Fausto Rigo, Costantino Astarita, Antonino Coppola, Carlo Romano, Nicola Capuano. Adv Ther 2015
38
Use-dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activity.
C Thollon, S Bedut, N Villeneuve, F Cogé, L Piffard, J-P Guillaumin, C Brunel-Jacquemin, P Chomarat, J-A Boutin, J-L Peglion,[...]. Br J Pharmacol 2007
C Thollon, S Bedut, N Villeneuve, F Cogé, L Piffard, J-P Guillaumin, C Brunel-Jacquemin, P Chomarat, J-A Boutin, J-L Peglion,[...]. Br J Pharmacol 2007
14
Suboptimal pharmacotherapeutic management of chronic stable angina in the primary care setting.
Francine C Wiest, Chris L Bryson, Marcia Burman, Mary B McDonell, Jorja G Henikoff, Stephan D Fihn. Am J Med 2004
Francine C Wiest, Chris L Bryson, Marcia Burman, Mary B McDonell, Jorja G Henikoff, Stephan D Fihn. Am J Med 2004
17
Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice.
Ralf Koester, Jan Kaehler, Henning Ebelt, Gerold Soeffker, Karl Werdan, Thomas Meinertz. Clin Res Cardiol 2010
Ralf Koester, Jan Kaehler, Henning Ebelt, Gerold Soeffker, Karl Werdan, Thomas Meinertz. Clin Res Cardiol 2010
35
Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
Florian Custodis, Magnus Baumhäkel, Nils Schlimmer, Franka List, Christoph Gensch, Michael Böhm, Ulrich Laufs. Circulation 2008
Florian Custodis, Magnus Baumhäkel, Nils Schlimmer, Franka List, Christoph Gensch, Michael Böhm, Ulrich Laufs. Circulation 2008
14
Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure.
Finlay A McAlister, Natasha Wiebe, Justin A Ezekowitz, Alexander A Leung, Paul W Armstrong. Ann Intern Med 2009
Finlay A McAlister, Natasha Wiebe, Justin A Ezekowitz, Alexander A Leung, Paul W Armstrong. Ann Intern Med 2009
14
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.
John J V McMurray, Stamatis Adamopoulos, Stefan D Anker, Angelo Auricchio, Michael Böhm, Kenneth Dickstein, Volkmar Falk, Gerasimos Filippatos, Cândida Fonseca, Miguel Angel Gomez-Sanchez,[...]. Eur Heart J 2012
John J V McMurray, Stamatis Adamopoulos, Stefan D Anker, Angelo Auricchio, Michael Böhm, Kenneth Dickstein, Volkmar Falk, Gerasimos Filippatos, Cândida Fonseca, Miguel Angel Gomez-Sanchez,[...]. Eur Heart J 2012
14
Ivabradine improves coronary flow reserve in patients with stable coronary artery disease.
Emmanouil I Skalidis, Michalis I Hamilos, Gregory Chlouverakis, Evangelos A Zacharis, Panos E Vardas. Atherosclerosis 2011
Emmanouil I Skalidis, Michalis I Hamilos, Gregory Chlouverakis, Evangelos A Zacharis, Panos E Vardas. Atherosclerosis 2011
20
Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials.
Kim Fox, Michel Komajda, Ian Ford, Michele Robertson, Michael Böhm, Jeffrey S Borer, Philippe Gabriel Steg, Luigi Tavazzi, Michal Tendera, Roberto Ferrari,[...]. Eur Heart J 2013
Kim Fox, Michel Komajda, Ian Ford, Michele Robertson, Michael Böhm, Jeffrey S Borer, Philippe Gabriel Steg, Luigi Tavazzi, Michal Tendera, Roberto Ferrari,[...]. Eur Heart J 2013
14
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur Heart J 2016
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur Heart J 2016
14
Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS)
N Rehnqvist, P Hjemdahl, E Billing, I Björkander, S V Eriksson, L Forslund, C Held, P Näsman, N H Wallén. Eur Heart J 1996
N Rehnqvist, P Hjemdahl, E Billing, I Björkander, S V Eriksson, L Forslund, C Held, P Näsman, N H Wallén. Eur Heart J 1996
12
Contributions of heart rate and contractility to myocardial oxygen balance during exercise.
Patrice Colin, Bijan Ghaleh, Xavier Monnet, Jinbo Su, Luc Hittinger, Jean-Francois Giudicelli, Alain Berdeaux. Am J Physiol Heart Circ Physiol 2003
Patrice Colin, Bijan Ghaleh, Xavier Monnet, Jinbo Su, Luc Hittinger, Jean-Francois Giudicelli, Alain Berdeaux. Am J Physiol Heart Circ Physiol 2003
12
Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells.
P Bois, J Bescond, B Renaudon, J Lenfant. Br J Pharmacol 1996
P Bois, J Bescond, B Renaudon, J Lenfant. Br J Pharmacol 1996
12
Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology.
A John Camm, Chu-Pak Lau. Drugs R D 2003
A John Camm, Chu-Pak Lau. Drugs R D 2003
12
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.